{"id":644,"date":"2015-07-29T12:05:37","date_gmt":"2015-07-29T06:35:37","guid":{"rendered":"https:\/\/delveinsightblog.wordpress.com\/?p=644"},"modified":"2025-05-05T17:19:11","modified_gmt":"2025-05-05T11:49:11","slug":"bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015","status":"publish","type":"post","link":"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015","title":{"rendered":"Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015"},"content":{"rendered":"<p>DelveInsight, the leading market research and consulting company has added new report \u00a0<strong>Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015<\/strong> to its portfolio. With this launch DelveInsight now has <strong>700+ Reports on Indication Pipeline Insight<\/strong>. In addition to this, our research expertise provides our clients with up to date information of market till the date order has been placed.<\/p>\n<p>This Indication pipeline Insight Report provides client with details on Bile Duct Cancer (Cholangiocarcinoma) drugs across the globe. It comprehensively includes:<\/p>\n<ul>\n<li>The report imparts<strong> information of 30+ pipeline drugs along with 25+ active company names<\/strong>, among which <strong>14 drugs are in phase II, 10 in phase I, 2 in pre &#8211; clinical and 1 in discovery phase.<\/strong><\/li>\n<li>Assessment of <strong>Porfimer Sodium pipeline drug in Phase III<\/strong> stage under development by <strong>Concordia Healthcare<\/strong>.<\/li>\n<li>R&amp;D activities and technologies used along with the pipeline molecules in development.<\/li>\n<li>Information related to <strong>collaborations, in-licensing and out-licensing deals<\/strong>.<\/li>\n<li>Stages of development of pipeline molecules.<\/li>\n<li>Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.<img decoding=\"async\" class=\"  wp-image-646 aligncenter\" src=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/bile-duct-cancer1.jpg?w=300\" alt=\"Bile Duct Cancer\" width=\"508\" height=\"324\" \/><\/li>\n<\/ul>\n<p>Bile Duct Cancer\u00a0Cholangiocarcinoma) Report envisages Pipeline Intelligence by <strong>identifying the key players along with their potential pipeline molecule<\/strong>. Therefore DelveInsight\u2019s report on Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights helps to <strong>optimize portfolio by creating effective counter-strategies to gain competitive and therapeutic advantage<\/strong> in global Pharma market. In addition, it assesses the major <strong>market drivers and barriers<\/strong> in development of Pipeline molecules which helps to understand market for <strong>collaborations and licensing deals<\/strong>.<\/p>\n<p>DelveInsight is offering the Report at a price of <strong>US 1,250<\/strong> as a single user license, <strong>USD 2,500<\/strong> as a site license and <strong>USD 4,000<\/strong> as a Global\/Enterprise License.<\/p>\n<p>For more information on Pipeline Insight Reports, email at <a href=\"mailto:info@delveInsight.com\">info@delveInsight.com<\/a><\/p>\n<p><strong>About Us:<\/strong><br \/>\nDelveInsight is a leading Business Consulting and Market Research Firm.\u00a0 We help our clients to find answers relevant to their business, facilitating decision-making; identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing<strong> custom research services in coherence with interest area of the clients.<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight, the leading market research and consulting company has added new report \u00a0Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015 to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight. In addition to this, our research expertise provides our clients with up to date information of market till the date order [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","advgb_blocks_editor_width":"","advgb_blocks_columns_visual_guide":"","footnotes":""},"categories":[17],"tags":[111,112,134,164,173,204,208,356,490],"industry":[17225],"therapeutic_areas":[17228,17234],"class_list":["post-644","post","type-post","status-publish","format-standard","hentry","category-articles","tag-bile-duct-cancer","tag-bile-duct-cancer-pipeline-insight-report","tag-business-consultant","tag-cholangiocarcinoma","tag-collaborations","tag-delveinsight","tag-delveinsight-pipeline-report","tag-licensing-opportunities","tag-porfimer-sodium-pipeline-drug","industry-pharmaceutical","therapeutic_areas-oncology","therapeutic_areas-rare-diseases"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v25.8 (Yoast SEO v25.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bile Duct Cancer Market | Delveinsight<\/title>\n<meta name=\"description\" content=\"DelveInsight, the leading market research and consulting company has added new report Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015 to its portfolio. With this launch DelveInsight. To get know more about Bile Duct Cancer Market visit now.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bile Duct Cancer Market | Delveinsight\" \/>\n<meta property=\"og:description\" content=\"DelveInsight, the leading market research and consulting company has added new report Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015 to its portfolio. With this launch DelveInsight. To get know more about Bile Duct Cancer Market visit now.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015\" \/>\n<meta property=\"og:site_name\" content=\"DelveInsight Business Research\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-07-29T06:35:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-05T11:49:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/bile-duct-cancer1.jpg?w=300\" \/>\n<meta name=\"author\" content=\"DelveInsight\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:site\" content=\"@DelveInsight\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DelveInsight\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bile Duct Cancer Market | Delveinsight","description":"DelveInsight, the leading market research and consulting company has added new report Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015 to its portfolio. With this launch DelveInsight. To get know more about Bile Duct Cancer Market visit now.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015","og_locale":"en_US","og_type":"article","og_title":"Bile Duct Cancer Market | Delveinsight","og_description":"DelveInsight, the leading market research and consulting company has added new report Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015 to its portfolio. With this launch DelveInsight. To get know more about Bile Duct Cancer Market visit now.","og_url":"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015","og_site_name":"DelveInsight Business Research","article_publisher":"https:\/\/www.facebook.com\/DelveInsight-1423323754607782\/","article_published_time":"2015-07-29T06:35:37+00:00","article_modified_time":"2025-05-05T11:49:11+00:00","og_image":[{"url":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/bile-duct-cancer1.jpg?w=300","type":"","width":"","height":""}],"author":"DelveInsight","twitter_card":"summary_large_image","twitter_creator":"@DelveInsight","twitter_site":"@DelveInsight","twitter_misc":{"Written by":"DelveInsight","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015","url":"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015","name":"Bile Duct Cancer Market | Delveinsight","isPartOf":{"@id":"https:\/\/www.delveinsight.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015#primaryimage"},"image":{"@id":"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015#primaryimage"},"thumbnailUrl":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/bile-duct-cancer1.jpg?w=300","datePublished":"2015-07-29T06:35:37+00:00","dateModified":"2025-05-05T11:49:11+00:00","author":{"@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a"},"description":"DelveInsight, the leading market research and consulting company has added new report Bile Duct Cancer (Cholangiocarcinoma) -Pipeline Insights, 2015 to its portfolio. With this launch DelveInsight. To get know more about Bile Duct Cancer Market visit now.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/bile-duct-cancer-cholangiocarcinoma-pipeline-insights-2015#primaryimage","url":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/bile-duct-cancer1.jpg?w=300","contentUrl":"https:\/\/delveinsightblog.files.wordpress.com\/2015\/07\/bile-duct-cancer1.jpg?w=300"},{"@type":"WebSite","@id":"https:\/\/www.delveinsight.com\/blog\/#website","url":"https:\/\/www.delveinsight.com\/blog\/","name":"DelveInsight Business Research","description":"Blog","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.delveinsight.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/5fbf6ca478835d03fdb5e17d905b520a","name":"DelveInsight","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.delveinsight.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/afdd550c64e18f6ad8957080b017c6ae55f4916951d641d3cd40264176aa0e86?s=96&d=mm&r=g","caption":"DelveInsight"}}]}},"author_meta":{"display_name":"DelveInsight","author_link":"https:\/\/www.delveinsight.com\/blog\/author\/gtadmin"},"featured_img":null,"coauthors":[],"tax_additional":{"categories":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Articles<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Articles<\/span>"]},"tags":{"linked":["<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Bile duct Cancer<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Bile Duct Cancer Pipeline Insight report<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Business Consultant<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Cholangiocarcinoma<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">collaborations<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">DelveInsight<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">delveinsight Pipeline report<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">licensing opportunities<\/a>","<a href=\"https:\/\/www.delveinsight.com\/blog\/articles\/\" class=\"advgb-post-tax-term\">Porfimer Sodium pipeline drug<\/a>"],"unlinked":["<span class=\"advgb-post-tax-term\">Bile duct Cancer<\/span>","<span class=\"advgb-post-tax-term\">Bile Duct Cancer Pipeline Insight report<\/span>","<span class=\"advgb-post-tax-term\">Business Consultant<\/span>","<span class=\"advgb-post-tax-term\">Cholangiocarcinoma<\/span>","<span class=\"advgb-post-tax-term\">collaborations<\/span>","<span class=\"advgb-post-tax-term\">DelveInsight<\/span>","<span class=\"advgb-post-tax-term\">delveinsight Pipeline report<\/span>","<span class=\"advgb-post-tax-term\">licensing opportunities<\/span>","<span class=\"advgb-post-tax-term\">Porfimer Sodium pipeline drug<\/span>"]}},"comment_count":"0","relative_dates":{"created":"Posted 11 years ago","modified":"Updated 12 months ago"},"absolute_dates":{"created":"Posted on Jul 29, 2015","modified":"Updated on May 5, 2025"},"absolute_dates_time":{"created":"Posted on Jul 29, 2015 12:05 pm","modified":"Updated on May 5, 2025 5:19 pm"},"featured_img_caption":"","series_order":"","_links":{"self":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/comments?post=644"}],"version-history":[{"count":1,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/644\/revisions"}],"predecessor-version":[{"id":31669,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/posts\/644\/revisions\/31669"}],"wp:attachment":[{"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/media?parent=644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/categories?post=644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/tags?post=644"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/industry?post=644"},{"taxonomy":"therapeutic_areas","embeddable":true,"href":"https:\/\/www.delveinsight.com\/blog\/wp-json\/wp\/v2\/therapeutic_areas?post=644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}